PetMed Express (NASDAQ:PETS) released its earnings results on Sunday. The company reported $0.34 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.06), MarketWatch Earnings reports. PetMed Express had a return on equity of 22.79% and a net margin of 9.82%. The business had revenue of $71.70 million during the quarter, compared to analysts’ expectations of $74.04 million. During the same quarter in the previous year, the business earned $0.35 EPS. The business’s revenue for the quarter was down 3.5% on a year-over-year basis.
Shares of PetMed Express stock traded up $0.79 during trading on Tuesday, hitting $30.27. 36,907 shares of the stock traded hands, compared to its average volume of 759,308. The firm has a market cap of $613.60 million, a P/E ratio of 19.65 and a beta of 0.70. PetMed Express has a 52-week low of $27.60 and a 52-week high of $57.00. The stock’s fifty day simple moving average is $32.75 and its 200 day simple moving average is $32.72.
The company also recently declared a quarterly dividend, which will be paid on Friday, May 21st. Stockholders of record on Friday, May 14th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 13th. This represents a $1.20 annualized dividend and a dividend yield of 3.96%. This is a positive change from PetMed Express’s previous quarterly dividend of $0.28.
Separately, Sidoti upgraded PetMed Express from a “neutral” rating to a “buy” rating in a research note on Thursday, March 11th.
PetMed Express Company Profile
PetMed Express, Inc, together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Featured Article: Cost of Equity For A Business, Investors
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.